Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

MRP1 (human) monoclonal antibody (QCRL-1)

ALX-801-010-L001 1 ml 605.00 USD
Do you need bulk/larger quantities?

Product Details

Alternative Name:Multidrug resistance-associated protein 1, ABCC1
Immunogen:Membranes prepared from the human small cell lung cancer cell line H69AR.
UniProt ID:P33527
Species reactivity:Human
Specificity:Recognizes the linear internal epitope (S918SYSGDI924) of human MRP1 (multidrug resistance-associated protein 1), overexpressed in various human non-P-glycoprotein MDR tumor cell lines.
Crossreactivity:Does not cross-react with human P-glycoprotein, MDR3 P-glycoprotein or human MRP2 (cMOAT) to MRP5, or mouse MRP gene products.
Applications:Flow Cytometry, ICC, IHC (PS), IP, WB
Recommended Dilutions/Conditions:Flow Cytometry (1:20)
Immunocytochemistry (1:20-1:50)
Western Blot (0.02-0.2µg/ml)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
Application Notes:Flow Cytometry: cell permeabilization required
Immunocytochemistry: cytospin preparations
Formulation:Liquid. 0.22μm-filtered solution in PBS containing 0.7% BSA and 0.1% sodium azide.
Handling:Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -20°C.
Shipping:Shipped on Blue Ice
Short Term Storage:+4°C
Long Term Storage:-20°C
Regulatory Status:RUO - Research Use Only
MRP1 (human) monoclonal antibody (QCRL-1) image
Figure: Human MRP1-specific MAb QCRL-1 (Prod.No. ALX-801-010)."
Please mouse over
MRP1 (human) monoclonal antibody (QCRL-1) image

Product Literature References

Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1): R. Daoud, et al.; Biochemistry 39, 15344 (2000), Abstract;
The multidrug resistance protein is photoaffinity labeled by a quinoline-based drug at multiple sites: R. Daoud, et al.; Biochemistry 39, 6094 (2000), Abstract;
ATPase activity of purified and reconstituted multidrug resistance protein MRP1 from drug-selected H69AR cells: Q. Mao, et al.; Biochim. Biophys. Acta 1461, 69 (1999), Abstract;
Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier: V.V. Rao, et al.; PNAS 96, 3900 (1999), Abstract; Full Text
Expression of the multidrug resistance protein (MRP1) in breast cancer: M. Filipits, et al.; Anticancer Res. 19, 5043 (1999), Abstract;
MRP expression in acute myeloid leukemia. An update: M. Filipits, et al.; Adv. Exp. Med. Biol. 457, 141 (1999), Abstract;
Epitope mapping of monoclonal antibodies specific for the 190-kDa multidrug resistance protein (MRP): D.R. Hipfner, et al.; Br. J. Cancer 78, 1134 (1998), Abstract;
Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung: S.R. Wright, et al.; Clin. Cancer Res. 4, 2279 (1998), Abstract;
Location of a protease-hypersensitive region in the multidrug resistance protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1: D.R. Hipfner, et al.; Cancer Res. 56, 3307 (1996), Abstract;
MRP and MDR1 gene expression in primary breast carcinomas: M. Filipits, et al.; Clin. Cancer Res. 2, 1231 (1996), Abstract;
Characterization of the M(r) 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cell: K.C. Almquist, et al.; Cancer Res. 55, 102 (1995), Abstract;
Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies: D.R. Hipfner, et al.; Cancer Res. 54, 5788 (1994), Abstract;

Product Toolbox


Certificate of Analysis


By target:
By biological activity:
MRP Monoclonal antibody
By catalog section:


Technical Service
Customer Service

Related Literature

Product Flyers
Detect Activity of Major ABC Transporter Proteins
Detect Activity of Major ABC Transporter Proteins
Download as PDF

All new literature pieces

Recommend this page

Keep in touch

©2022 Enzo Life Sciences, Inc.,